Back to Search

LEO PLOUFFE, MD

MD

Multi-Specialty Clinic/Center

NPI: 1912082314Individual

Specialties, Licenses & Credentials

Multi-Specialty Clinic/CenterPrimary

Clinic/Center — Multi-Specialty

Code: 261QM1300X

01048385A(IN)

Research & Publications (20)

The effect of selective estrogen receptor modulators on parameters of the hypothalamic-pituitary-gonadal axis.
PMID 11795360·Ann N Y Acad Sci·2001
6-review
Disorders of excessive hair growth in the adolescent.
PMID 10693184·Obstet Gynecol Clin North Am·2000
6-review
When ageing and disasters collide: lessons from 16 international case studies.
PMID 19435731·Radiat Prot Dosimetry·2009
8-other
Increased incorporation of dietary plant sterols and cholesterol correlates with decreased expression of hepatic and intestinal Abcg5 and Abcg8 in diabetic BB rats.
PMID 18547796·J Nutr Biochem·2009
7-preclinical
Ctr2 is partially localized to the plasma membrane and stimulates copper uptake in COS-7 cells.
PMID 17944601·Biochem J·2008
7-preclinical
Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass.
PMID 17182297·Bone·2007
4-observational
Duloxetine in the treatment of women with stress urinary incontinence: results from DESIRE (Duloxetine Efficacy and Safety for Incontinence in Racial and Ethnic populations).
PMID 17076972·Curr Med Res Opin·2006
3-trial
Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women.
PMID 16260540·Obstet Gynecol·2005
8-other
The dopamine receptor D2 genotype is associated with hyperprolactinemia.
PMID 16169407·Fertil Steril·2005
4-observational
Limited effects of combined dietary copper deficiency/iron overload on oxidative stress parameters in rat liver and plasma.
PMID 16098731·J Nutr Biochem·2005
7-preclinical
Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trial.
PMID 15025844·Curr Med Res Opin·2004
4-observational
Rationale for a non-inferiority clinical trial design focused on subpopulations.
PMID 15462697·Curr Med Res Opin·2004
8-other
Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation.
PMID 15458908·Obstet Gynecol·2004
3-trial
Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis.
PMID 15341559·J Am Geriatr Soc·2004
4-observational
Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
PMID 14754694·Obstet Gynecol·2004
3-trial
Comparative health effects of margarines fortified with plant sterols and stanols on a rat model for hemorrhagic stroke.
PMID 14870926·Lipids·2003
4-observational
Carbohydrate metabolism in erythrocytes of copper deficient rats.
PMID 14629896·J Nutr Biochem·2003
7-preclinical
Effect of raloxifene on sexual function in postmenopausal women.
PMID 14567773·Climacteric·2003
3-trial
Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy.
PMID 12576260·Obstet Gynecol·2003
3-trial
Effects of oral raloxifene on serum estradiol levels and other markers of estrogenicity.
PMID 12215319·Fertil Steril·2002
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
ELI LILLY AND COMPANY, LILLY CORPORATE CENTER
INDIANAPOLIS, IN 46285

Location

Practice Location

ELI LILLY AND COMPANY, INDIANAPOLIS, IN
(317) 997-5141

Quick Facts

NPI
1912082314
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile